Thoracic Transplantation
The International Society for Heart and Lung Transplantation (ISHLT)
Type of Organization: Foundation
Email Address: information@ishlt.org
Funds Available for Clinical Trials:
✗ Research:
✔
Funding Details
Requirements: Academic Appointment and Institutional Resources
The applicant may have an academic or clinical appointment or may be in training at an accredited institution.
A letter of institutional commitment from a division or department chair at the institution at which the research will be conducted must be provided.
ISHLT Membership
The applicant must be an active member of ISHLT or have submitted a completed membership application by 31 December.
Previous ISHLT Funding/Funding from Other Sources
There are no restrictions on past or current funding.
The applicant may be a past or current recipient of ISHLT funding, including Fellowship or Faculty Development research grants.
The applicant may currently hold career development awards, mentoring awards, or other independent research awards.
If the applicant is currently receiving funding for a project similar to the topics described in this request for applications, the applicant must explain how the funds of the grant would not overlap with the funds of the other research support.
Miscellaneous
Applicants who have a substantial relationship with Mallinckrodt Pharmaceuticals that would present a real or perceived conflict of interest if awarded this grant must first contact ISHLT to declare the conflict before submitting an application. Examples of a substantial relationship include board member, member of an advisory council, consultant, lecturer, etc.
Employees of Mallinckrodt cannot submit an application.
Upon disclosure, the Grants and Awards Committee will determine if the individual is eligible to submit an application and will notify the individual in a timely manner.
Other info: Purpose
The purpose of this grant is to fund research that is aimed at advancing the use of ECP immunomodulation to improve outcomes in thoracic transplant patients.